Score
1
1989
pubmed
[The effect of thymalin on indices of immunity and hemostasis in patients with disseminated forms of psoriasis].
Isaeva. M P MP; Budazhabon. G B GB; Kuznik. B I BI
Key Findings
- Thymalin combined with usual therapy normalized immune system markers in psoriasis patients
- Hemostasis (blood clotting) parameters showed improvement with thymalin
- Patients experienced a noticeable improvement in psoriasis clinical status
Practical Outcomes
- For biohackers, this suggests thymalin might have immune‑modulating effects, but the evidence is limited to a skin condition and lacks dosage or safety details. It isn’t a ready‑to‑use protocol for longevity or performance, and more research is needed before practical application.
Summary
Adding the peptide thymalin to standard psoriasis treatment helped bring immune and blood clotting measures back toward normal and made patients' skin symptoms better, but the study only looked at skin disease, not overall health or longevity.
Abstract
Use of thymalin in combined therapy of psoriasis patients has resulted in normalization (complete or incomplete) of the immunity and hemostasis parameters; this has been parallelled by improvement of the clinical status of the patients.
Study Information
Provider
pubmed
Year
1989